News-Excellence achieved through unity and diversity. Convergence and condensation result in crystallization.

Excellence achieved through unity and diversity. Convergence and condensation result in crystallization.

Homepage > News
19 2025-06

Several key raw materials, including AKG, have obtained food production licenses, laying a solid foundation for the health industry.

In the heat of midsummer, June, there are frequent pieces of good news! Following the successful certification of products such as γ-aminobutyric acid (GABA) and L-aspartic acid, Jingjing Pharmaceutical is once again experiencing a glorious moment. Its portfolio now includes AKG (α-ketoglutaric acid, 2-oxoglutaric acid), β-alanine, calcium aspartate, L-arginine, isomaltulose, ferrous fumarate, L-malic acid, and more...

04 2025-06

Jingjing Pharmaceutical produces 30,000 tons of aspartic acid annually, and the price has been reduced to the lowest possible level.

Strict control over raw materials to ensure purity; Biological enzyme catalysis for leading quality; Precise control for worry-free crystallization; Full traceability to address any issues; Multiple uses for the same material, ensuring stable quality; Same purity at a lower price, with the option for customization!

26 2025-05

Crystalline Pharmaceutical's Global Exhibition Highlights | Zhengzhou, Barcelona, Guangzhou: Three Events Linked Together to Embrace a Healthy Future!

Jingjing Pharmaceutical makes a grand appearance at three major industry events, bringing its core products and innovative technologies. We sincerely invite colleagues from all fields to join us for exchanges and jointly explore new development opportunities! FIE ASia Huatao·2025 Henan (Zhengzhou) International Food Additives and Ingredients Expo: Date: May 23-25 Location: Zhengzhou Zhongyuan International Expo Center Booth: A25,...

24 2025-05

The 2024 Annual General Meeting of Shareholders of Jingjing Pharmaceutical Co., Ltd. was successfully held.

On May 16th, the 2024 annual general meeting of shareholders of Jingjing Pharmaceutical was successfully held. The meeting was chaired by Chairman Li Binshui. During the meeting, Chairman Li Binshui provided a comprehensive overview of the company's operations for the year 2024 and the work plan for 2025. He also focused on the company's latest developments, new product research and development, future development strategies, technological innovations, and talent management...

07 2025-02

Jingjing Pharmaceutical Hazardous Waste Management System

Jingjing Pharmaceutical - Hazardous Waste Management System.pdf

07 2025-02

Jingjing Pharmaceutical Xingtai Food Additives Branch 2025 Hazardous Waste Management Plan

Jingjing Pharmaceutical Xingtai Food Additives Branch 2025 Hazardous Waste Management Plan.pdf